—

Medline Inc. Class A Common Stock (MDLN) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for MDLN, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 61/100 · S&P 500 fund at 75, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-06
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 98th percentile of the window, +5.7% over 20 sessions. Factor regime → 2026-10-06
  • Sector × region Health care in US: −2.1% week · −2.2% month · +3.3% quarter · +16.4% yearThe Sector Engine cell this name lives in, from XLV.US; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-10-06
  • Sovereign pressure Index 0.74 · up 0.17 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-06
How it trades on rate days beta 0.47 to TLT · on the worst bond days it fell more than the market

How it trades on rate days

How MDLN has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.47 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), Medline Inc. Class A Common Stock moved 0.47% on average · correlation 0.10 · higher than 49% of US names
  • Beta, last 3 months 0.83 more rate-sensitive lately than over the year
  • On the 10 worst bond days −1.75% on average against −0.74% for the S&P 500 the 9 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +1.05% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Medical Instruments & Supplies · 8 names with week and year-to-date

Peer group

Medical Instruments & Supplies

Names in the same industry from the Closelooknet universe; scored names rank on their Closelooknet score, the rest on trend state.

Compared against MDLN on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Medline Inc. Class A Common Stock

MDLN in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Medline makes medical and surgical products used across hospitals, surgery centres, physician offices, post-acute sites and nursing homes in the United States and abroad. It runs two segments: Medline Brand, which manufactures surgical solutions, front-line patient care items and laboratory and diagnostic products, and Supply Chain Solutions, which distributes third-party brands and runs logistics and inventory services for care providers. It is based in Northfield, United States.
Where it sits in the stack
Medline holds no seat in Rubin or Halo, the diary's two build-out indices, because its products are hospital and surgical supplies rather than compute infrastructure. In our universe it sits in the Healthcare sleeve, grouped by sector and country rather than by any layer of the AI stack.
Who it is priced against
Closelooknet's peer group here is Healthcare names listed in the US, drawn together simply because they share sector and country: argenx, Medpace, BeiGene, Globus Medical, Regeneron, Veeva Systems, Vertex Pharmaceuticals and Corcept Therapeutics. The market also names Cardinal Health as a comparable distributor of medical supplies.
Why Closelooknet tracks it
Medline carries a Closelooknet score with valuation as its strongest module and momentum as its weakest; it holds no seat in Rubin or Halo and no quotes appear in the diary's editions yet.
What the diary watches
The diary watches whether the momentum reading recovers as the newly listed shares trade through a fuller history, and whether the valuation strength holds against that.

Medline Inc. Class A Common Stock (MDLN) trades on US exchanges, classified under Healthcare.

The Closelooknet company score reads 44/100 composite (momentum 16, quality 33, valuation 42) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 1 analyst action on the wire · latest: price target by UBS, 2026-09-25

The Street on this name

Analyst actions and the latest print for MDLN from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target UBS — target 43 from 45 Target cut to $43 from $45 (+23.5% to spot) 2026-09-25

1 action on the analyst wire since 2026-08-13: 1 target change. Analyst wire → · Earnings wire →

Dividends and capital return no distribution in twelve months · buybacks 2.00 bn USD in FY2025

Dividends and capital return

What MDLN pays out and buys back — distributions read from the price series, money terms from the filings.

  • Distributions No cash distribution recorded in the price series over the last three years
  • Buybacks, FY2025 2.00 bn USD 4.2% of today's market value
  • Share count +3.2% in FY2025 76 m USD of stock-based compensation in the year
  • Capital returned 2.00 bn USD · 154% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-10-07

Quick answers

What is Medline Inc. Class A Common Stock (MDLN)?

Medline Inc. Class A Common Stock trades as MDLN on the US exchange (US) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-10-07.

Is MDLN in a Closelooknet index?

Not currently — Medline Inc. Class A Common Stock is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-07.

What is Medline Inc. Class A Common Stock's Closelooknet composite score?

44 out of 100, with momentum 16, quality 33 and valuation 42 sub-scores, as of 2026-10-07. Scores are Closelooknet's own research readings, not ratings or investment advice.

How does Medline Inc. Class A Common Stock trade when bond yields rise?

Over the past year Medline Inc. Class A Common Stock had a beta of 0.47 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 49% of US names. On the 9 sessions in which long bonds fell most it moved −1.75% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Medline Inc. Class A Common Stock do?

Medline makes medical and surgical products used across hospitals, surgery centres, physician offices, post-acute sites and nursing homes in the United States and abroad. It runs two segments: Medline Brand, which manufactures surgical solutions, front-line patient care items and laboratory and diagnostic products, and Supply Chain Solutions, which distributes third-party brands and runs logistics and inventory services for care providers. It is based in Northfield, United States. Closelooknet's peer group here is Healthcare names listed in the US, drawn together simply because they share sector and country: argenx, Medpace, BeiGene, Globus Medical, Regeneron, Veeva Systems, Vertex Pharmaceuticals and Corcept Therapeutics. The market also names Cardinal Health as a comparable distributor of medical supplies.

Where does Medline Inc. Class A Common Stock sit in the AI build-out?

Medline holds no seat in Rubin or Halo, the diary's two build-out indices, because its products are hospital and surgical supplies rather than compute infrastructure. In our universe it sits in the Healthcare sleeve, grouped by sector and country rather than by any layer of the AI stack. Medline carries a Closelooknet score with valuation as its strongest module and momentum as its weakest; it holds no seat in Rubin or Halo and no quotes appear in the diary's editions yet.

Does Medline Inc. Class A Common Stock pay a dividend?

No cash distribution shows in Medline Inc. Class A Common Stock’s price series over the last three years. In fiscal 2025 the company bought back 2.00 bn USD of its own shares, 154% of that year’s free cash flow. The share count rose 3.2% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Medline Inc. Class A Common Stock recently?

The most recent analyst action on Medline Inc. Class A Common Stock on the Closelooknet wire is a price target by UBS on 2026-09-25 (target 43 from 45). 1 action on the analyst wire since 2026-08-13: 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for MDLN, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Instruments & Supplies. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.